PATHOLOGY & BILLING GROUP PENSION PLAN
ERISA Form 5500 plan record drawn from DOL EBSA — verify with linked source filings below.
GENESIS LABORATORY MANAGEMENT, LLC
This Other plan holds $2M in total assets and serves 98 participants as of 2022. It is sponsored by GENESIS LABORATORY MANAGEMENT, LLC in New Jersey. The plan reported a net loss of $537K for the year.
What the Filing Says About PATHOLOGY & BILLING GROUP PENSION PLAN
PATHOLOGY & BILLING GROUP PENSION PLAN is a Other retirement plan sponsored by GENESIS LABORATORY MANAGEMENT, LLC, headquartered in New Jersey. As of the 2022 Form 5500 filing, the plan reports $2M in total end-of-year assets and covers 98 participants across the Healthcare & Social Assistance industry. The sponsor's EIN on file with the U.S. Department of Labor is 263844242, and the plan has been effective since 2017-01-01. Its filing status is currently FILING RECEIVED.
Year over year, total assets moved from $2M at the beginning of 2022 to $2M at year-end — a decline of 26.4%. Net assets (after liabilities) closed the year at $2M, with reported net income of $-537,378 driven by investment returns, contributions received, and benefit payments during the period. These figures reflect what the plan administrator certified on Schedule H or Schedule I of the Form 5500 annual return and can be compared against 2 prior plan-year filings from the same sponsor shown below.
Asset totals and participant counts reflect a single plan year snapshot and can change materially with market conditions, plan mergers, or workforce changes. Fields such as "net income" include both realized investment performance and contribution/distribution flows — a single-year figure does not by itself indicate plan health or participant outcomes. This page summarizes public DOL disclosures for research and educational purposes only and is not retirement, tax, legal, or financial advice. Before making decisions about your own retirement benefits or evaluating an employer's plan, verify the underlying filing directly via the DOL EFAST2 system and consult a qualified professional.
Financial Summary (2023)
| Total Assets (Beginning of Year) | $2M |
| Total Assets (End of Year) | $2M |
| Net Assets (End of Year) | $2M |
| Net Income | $-537,378 |
| Plan Type | Other |
| Employer EIN | 263844242 |
| Plan Effective Date | 2017-01-01 |
| Filing Status | FILING RECEIVED |
Sponsor Plan History (GENESIS LABORATORY MANAGEMENT, LLC)
| Year | Plans | Participants | Total Assets |
|---|---|---|---|
| 2022 | 2 | 196 | $6M |
| 2023 | 2 | 264 | $7M |
| 2024 | 1 | 112 | $6M |
Nearby Other Plans in New Jersey
Peer Other plans — same state, same plan type — ranked by total assets.
- LUCENT TECHNOLOGIES INC. PENSION PLAN $4.2B · N/A
- CONSOLIDATED ROCHE RETIREMENT PLAN $3.2B · 2,130
- TEAMSTERS PENSION TRUST FUND OF PHILADELPHIA & VICINITY $2.4B · 10,032
- HEAVY AND GENERAL LABORERS' LOCAL UNIONS 472 AND 172 OF NEW JERSEY PENSION FUND $1.6B · 7,170
- RWJBARNABAS HEALTH 403(B) SAVINGS PLAN $1.3B · 28,672
Related Data
Guides
Frequently Asked Questions
How much money is in the PATHOLOGY & BILLING GROUP PENSION PLAN? ▼
What type of plan is PATHOLOGY & BILLING GROUP PENSION PLAN? ▼
Who sponsors the PATHOLOGY & BILLING GROUP PENSION PLAN? ▼
How did PATHOLOGY & BILLING GROUP PENSION PLAN perform in 2022? ▼
Where can I find official filings for PATHOLOGY & BILLING GROUP PENSION PLAN? ▼
How does PATHOLOGY & BILLING GROUP PENSION PLAN compare to other plans? ▼
Explore PlainRetire
Source: U.S. Department of Labor, Employee Benefits Security Administration (EBSA), Form 5500 public disclosure dataset. Plan year 2022.
Source: DOL EFAST2 filing system (efast.dol.gov) — original filing retrieval by EIN 263844242.
Reference: IRS Publication 560 — Retirement Plans for Small Business, contribution-limit rules.
Reference: IRS Publication 590-B — Distributions from IRAs, RMD rules under SECURE Act 2.0.
Read our methodology — how this data is sourced, computed, and verified.